Results 51 to 60 of about 3,721,297 (234)
Risperidone is a commonly used antipsychotic for treating psychiatric illness in children and adolescents. There is a large variability in risperidone response and discontinuation rates remain high. Pharmacogenomics offers the opportunity to improve risperidone outcomes, yet studies in pediatric populations are limited.
Jack W. Staples +10 more
wiley +1 more source
Substance-induced psychosis: A diagnostic conundrum
Objective: To critically examine the DSM-IV-TR criteria for substance-induced psychotic disorder (SIPD). Data Sources: Leading electronic databases (such as MEDLINE, PubMed) were searched for the years 1992 through 2007, using combinations of the ...
Mathias, Steve +5 more
core +1 more source
Differentiation of Substance-Induced Psychosis and Schizophrenia with Emphasis on Clinically Observable Specifics [PDF]
Background: In recent decades there has been a significant increase in the prevalence of substance-induced psychoses (SIP) in the Czech Republic. In the case of prolonged or recurrent SIP it often remains unclear whether to classify these conditions as ...
Pondělíková, Anežka
core +1 more source
Background Disturbances of the minimal self, or anomalous self-experiences (ASEs), are increasingly regarded as a core feature of primary psychotic disorders (PPDs).
Luisa De Risio +6 more
doaj +1 more source
This review highlights the misuse of antidepressants as potential cognitive‐enhancing agents in Esports. Despite pharmacological effects that overlap with those of psychostimulants, antidepressants remain an under‐recognised source of doping in Esports.
Kassim Ali Salum +4 more
wiley +1 more source
A comparison and contrast of cannabis and amphetamine-type stimulant induced psychoses
BackgroundThe term “psychosis” is very broad. Substance users represent one group with particularly high rates of psychotic symptoms.ObjectiveThis review will present an update on cannabis and amphetamine-type Stimulant (ATS) and will try to ...
F. Alharbi
core +1 more source
ABSTRACT Objective Psychotherapy is the first‐line treatment for eating disorders (EDs), yet only about half of patients benefit long‐term. Bulimia nervosa (BN), Binge‐Eating‐Disorder (BED), and non‐underweight EDs with regular binge eating (> 2 binge‐eating episodes per month within the last 3 months) (OSFED/UFED) form a transdiagnostic group ...
Sebastian M. Max +7 more
wiley +1 more source
ABSTRACT Objective This study examined differences in mental health and well‐being, risk behaviors, suicidality, and social functioning across a proposed eating disorder (ED) spectrum, ranging from no ED symptoms to clinically diagnosed EDs. Methods We examined 44,303 participants in the 18‐year follow‐up in the Danish National Birth Cohort (DNBC‐18 ...
Anne V. Aurup +6 more
wiley +1 more source
ABSTRACT Objective Loss of control (LOC) eating in children is prospectively associated with excessive weight gain and elevated psychopathology. Parental LOC eating and negative mood in children have been linked to child LOC eating; however, objective evidence on parent–child concordance in energy intake and sense of LOC over eating, particularly in ...
Sarah Maria Luise Thorwarth +2 more
wiley +1 more source
TULP4, a novel E3 ligase gene, participates in neuronal migration as a candidate in schizophrenia
Mutations identified from four SCZ pedigrees resulted in decreased TULP4 expression. Tulp4 knockdown caused delayed neuron migration in embryonic mice, and impaired cognition and prepulse inhibition in adult mice. These phenotypes may be related to TULP4 through its involvement in the formation of a novel E3 ubiquitin ligases.
Yan Bi +19 more
wiley +1 more source

